PTCH1 has an important role for embryonic structuring and cell cycle, and thus its genetic alteration can cause a key event for the development of the disease. It is important to genetically diagnose the disease to prevent its fatal consequences such as multiple skin cancers and other malignant tumors.
A 19-year-old female with the first episode of a primary spontaneous pneumothorax was referred to our hospital. Her left lung was completely collapsed in chest X-ray, although she had almost no respiratory symptoms. She was a non-smoker without any history of pulmonary diseases. She was born at her parents ages in early thirties, and there is no other cases of NBCCS in her family. She had undergone surgery for four times because of keratocystic odontogenic tumor (formerly called odontogenic keratocyst) in the upper jaw. Despite chest tube drainage for 5 days, air leakage persisted and thoracoscopic lung resection was selected. Intraoperatively we found pleural adhesion at the superial segment of the left lower lobe. The visceral pleura of the left lung appeared generally edematous. A cystic lesion was found at the lowest part of the dorsobasal segment of the left lower lobe and was resected with a stapler. Interestingly, the surface of the lesion appeared unusually thick for a bulla with an appearance similar to other parts of the visceral pleura ( Figure 1a) . Macroscopically, the cystic lesion had smooth surface and unevenly thickened wall (Figure 1b,c) . There remained persisted air leakage for 7 days postoperatively and eventually she underwent rethoracotomy; since then there has been no evidence of relapse to date for more than 20 months. We diagnosed her as NBCCS because she fulfilled two major criteria for NBCCS: bilamellar calcification of the falx cerebri and keratocystic odontogenic tumor (Supplementary Table 1 ). 5 Sections of 4 μm in thickness were used for hematoxylin and eosin staining and immunocytochemical analysis (Figure 2 ). For immunostaining, antibodies were used to detect alpha-smooth muscle actin and desmin (Dako corporation, Code No. N1584 and N1526, respectively). The detection was on the basis of the Labeled Streptavidin Biotin method (Bench Mark GX VENTANA).
The study was approved by a local ethical committee and informed consent was obtained from the patient and parents. Genomic DNA was extracted from peripheral blood leukocytes with a standard method using proteinaseK and phenol. Nine pairs of oligonucleotide primers were designed for the amplification of the 23 exons of the PTCH1 gene (Supplementary Table 2 ). PCR was performed using PrimeSTAR Max DNA Polymerase (Takara Bio, Shiga, Japan) according to the manufacturer's protocol. PCR products were resolved on a 1% agarose gel and purified with the Wizard SV Gel and PCR Clean-Up System (Promega, Tokyo, Japan). Sequencing of PCR products was performed on an ABI 373A automated sequencer (Life Technologies). The sequences obtained were aligned with a genomic sequence (NG_007664) as well as a full-length complementary DNA sequence of PTCH1 (NM_000264.3). To confirm the results of direct sequencing, PCR products with P3F and P3R covering exon 4 to exon 8 were cloned into pGEM-T Easy vector (Promega) and sequenced with T7 and SP6 vector primers. The exon numbers and the annotation of the detected mutation were given on the basis of the mRNA sequence of NM_000264.3 according to the recommendation of the Human Genome Variation Society (http://www.hgvs.org/mutnomen/ refseq.html).
The histological examination of the cystic lesion revealed the followings. The cysts were lined by columnar cells with no atypia (Figure 2a) , and underlying stroma was mainly composed of loose connective tissue with inflammatory cells (Figure 2b ) and the (Figure 2c ). They were confirmed to be smooth muscle cells using immunohistochemistry (Figure 2d ,e). These structures resembled respiratory tract tissue, and the cyst was covered with fibrous thickening visceral pleura (Figure 2f ). These findings were not the histological feature in the pneumothorax; therefore, hamartoma-like lesion or reactive change possibly associated with NBCCS should be considered.
We have undertaken a genetic analysis of the PTCH1 gene using direct sequencing. Two genetic alterations were identified in PTCH1 of the patient. The first was located in exon 8 and was an insertion of T nucleotide (c.1207dupT) in one of the two alleles, leading to a premature truncation of the PTCH1 protein with 33 aberrant amino acids in its C terminus (Figure 3a) . This mutation was localized in the first extracellular loop of the PTCH1 protein carrying 12 transmembrane domains. The insertion was confirmed by sequencing each allele using the cloned PCR products. We also examined whether this insertion was observed in her parents' genome. As the mutation was not present in either of her parents, it was a de novo germ-line mutation specific to the patient (Figure 3a) . The second genetic alteration, a T to C transition that leads to an amino-acid substitution from leucine to proline, was found in exon 23 for one of the two alleles of the patient (Figure 3b ). The genetic variant was registered in dbSNP as rs357564, and the frequency of C allele was reported as 0.384 in the Japanese population of the International HapMap Project. It was indeed observed in her unaffected mother. We therefore concluded that c.1207dupT was the causative genetic mutation.
NBCCS manifests multiple defects involving the skin, nervous system, eyes, endocrine system and bones. Because different disease phenotypes appear in multiple organs of patients at their early ages, an early and accurate diagnosis is extremely important for clinicians to evaluate signs and symptoms of the disease and to undertake appropriate treatments. The diagnostic criteria for NBCCS were established 6 and modified in 1997. 5 According to the criteria, the diagnosis can be established when the patient satisfies either two major or one major and two minor clinical manifestations (Supplementary Table 1 ). In our case, two major manifestations, namely, keratocystic odontogenic tumor and bilamellar calcification of falx cerebri (Figure 1d and e), and two minor manifestations of macrocephaly adjusted for height and frontal bossing were observed. Although there are some other clinical manifestations related to the disease as shown in Supplementary Table 1 , there are no such complications so far in the patient. To our knowledge, there was only one case of a NBCCS patient with large congenital cyst reported in a family consisting of four NBCCS cases. 7 The patient showed similar clinical manifestations with our case: the onset of pneumothorax in their juvenile and the presence of smooth muscle bundles in the cyst wall. Although no genetic analysis was undertaken for this family, the four patients were most likely to share the same genetic mutation. The reason for such a cyst in only one of the four cases was speculated as either an additional manifestation of NBCCS or simply a coincidental finding in one case.
Sequencing analysis of the whole exons of PTCH1 identified a novel single-nucleotide insertion in c.1207dupT resulting in a frameshift at the amino acid. Most of the abnormal mRNAs were reported to be degraded via a mechanism called nonsensemediated mRNA decay. In the present case, however, a truncated PTCH1 protein with 33 aberrant amino acids at its carboxyl terminus is likely to be synthesized and caused disease phenotypes. The PTCH protein has 12 transmembrane domains and two large extracellular loops.
8 PTCH1 is involved in the hedgehog (HH) pathway and served as a receptor for the HH ligand. 9 Two extracellular loops are coded in exons 2-9 and exons 15-18 in PTCH1, 10 and the second extracellular loop of PTCH1 works as receptor for the HH ligand.
11 HH signaling is a key regulator of embryonic development and tumorigenesis controlling cellular proliferation. Therefore, truncated PTCH1 protein because of this insertion in exon 8 could result in an aberrant cell cycle progression and neoplastic growth. 
